Skip to main content
Top
Published in: Journal of Experimental & Clinical Cancer Research 1/2018

Open Access 01-12-2018 | Correction

Correction to: Liver cancer cell lines distinctly mimic the metabolic gene expression pattern of the corresponding human tumours

Authors: Zeribe C. Nwosu, Nadia Battello, Melanie Rothley, Weronika Piorońska, Barbara Sitek, Matthias P. Ebert, Ute Hofmann, Jonathan Sleeman, Stefan Wölfl, Christoph Meyer, Dominik A. Megger, Steven Dooley

Published in: Journal of Experimental & Clinical Cancer Research | Issue 1/2018

Login to get access

Excerpt

In the publication of this article, the concentration of CB-839 in Fig. 5b was inadvertently written as mM. This has now been updated to μM in the original article [1]. The authors declare that the correction does not change the results or conclusions of this paper. …
Metadata
Title
Correction to: Liver cancer cell lines distinctly mimic the metabolic gene expression pattern of the corresponding human tumours
Authors
Zeribe C. Nwosu
Nadia Battello
Melanie Rothley
Weronika Piorońska
Barbara Sitek
Matthias P. Ebert
Ute Hofmann
Jonathan Sleeman
Stefan Wölfl
Christoph Meyer
Dominik A. Megger
Steven Dooley
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Journal of Experimental & Clinical Cancer Research / Issue 1/2018
Electronic ISSN: 1756-9966
DOI
https://doi.org/10.1186/s13046-018-0939-4

Other articles of this Issue 1/2018

Journal of Experimental & Clinical Cancer Research 1/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine